Approval of Audited Financial Results (Standalone and Consolidated) of the Company Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2026 and Asset ....
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Neogen Chemicals reported standalone revenue of ₹855.49 crore for FY2026, up 10.6% from ₹773.65 crore in FY2025. However, profit after tax declined 3% to ₹46.96 crore from ₹48.41 crore. The auditor issued an unmodified opinion but included an Emphasis of Matter regarding the March 2025 Dahej SEZ fire incident where a ₹348.16 crore loss was partially offset by a ₹334.60 crore insurance claim (net exceptional item of ₹13.56 crore in FY25). The company still has ₹188.96 crore insurance claim receivable outstanding. Operating cash flow turned significantly negative at ₹99.20 crore due to increased working capital tied up in inventory and receivables. The Board recommended a dividend of ₹1 per share. Subsidiary Neogen Ionics revised its Dahej and Pakhajan project cost upwards to ₹1,795 crore with commercial operations deferred to 2027.
The PAT decline despite revenue growth and negative operating cash flow may concern investors, though the unmodified audit opinion and insurance claim status provide some comfort. The expanded debt-funded capex in the subsidiary increases financial leverage risk.